Impact of Pharmaceutical Interviews Regarding the Management of Adverse

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT05421312` - Periarticular Penetration of Cefazolin and Clindamycin in Second Stage Revision Arthroplasty of the Hip	Phase 4
Active, not recruiting	`NCT04563325` - Oral-only Antibiotics for Bone and Joint Infections in Children	Phase 4
Completed	`NCT03627000` - Microbiological Epidemiology in Patients Experiencing Microbiological or Clinical Failure Following Reimplantation After a 2-stage Exchange Strategy for Hip or Knee Prosthetic Joint Infection
Completed	`NCT03311113` - Adherence to Oral Antibiotics In Patients With Osteoarticular Infections
Recruiting	`NCT05753215` - Controlled Trial of Omadacycline Randomized Treatment Given for Bone and Joint Infection	Phase 2
Completed	`NCT03209921` - Pharmacokinetic Variability of Daptomycin During Prolonged Therapy for Bone and Joint Infections	N/A
Completed	`NCT04418882` - Septic Management and Outcome of Open Fracture
Completed	`NCT03624855` - Implant-Associated P. Aeruginosa Bone And Joint Infections : Experience In A Regional Reference Center In France
Recruiting	`NCT04496024` - Ofloxacin Concentration-toxicity Relationship in the Elderly	N/A
Recruiting	`NCT04933344` - Pharmacokinetics and Toxicodynamics of Daptomycin in Bone and Joint Infections
Recruiting	`NCT04538053` - BonE and Joint Infections - Simplifying Treatment in Children Trial	Phase 4
Completed	`NCT04373278` - Infection After Free Fibula Flap Reconstruction of the Mandible: a Retrospective Cohort Study
Completed	`NCT03209934` - Daptomycin > 6 mg/kg/Day as Salvage Therapy in Patients With Complex Bone and Joint Infection: Cohort Study in a Regionalreference Center	N/A
Recruiting	`NCT02817711` - Lyon BJI Cohort Study	N/A
Recruiting	`NCT03611634` - Consitution Of A Biological Collection From Samples From The Gut Microbiote In Patients Having A Bone Or Joint Infection Treated By A Suppressive Subcutaneous Antibiotherapy With Betalactamine
Completed	`NCT03177369` - Teicoplanin-based Antimicrobial Therapy in Staphylococcus Aureus Bone and Joint Infection: Tolerance, Efficacy and Experience With Subcutaneous Administration	N/A
Recruiting	`NCT04722926` - Lyon PJI Retrospective Cohort Study
Completed	`NCT03852784` - Osteoarticular Infections With Pneumococcal
Recruiting	`NCT03796104` - Prognostic Impact of Delta-haemolysin Production Deficiency in Staphylococcus Aureus on the Prognosis of Infected Implant Treated by DAIR
Completed	`NCT03848104` - Evaluation of the Use of Cefoxitin in Combination in Continuous Parenteral Administration in the Treatment of Bone and Joint Infections

NCT number	NCT05248490
Study type	Interventional
Source	Assistance Publique - Hôpitaux de Paris
Contact
Status	Active, not recruiting
Phase	N/A
Start date	March 22, 2022
Completion date	May 3, 2024

Impact of Pharmaceutical Interviews Regarding the Management of Adverse Effects Related to the Antibiotic Therapy Used to Treat Osteoarticular Infections During Return Home — EFIRAD

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms